Skip to main content
Top
Published in: Inflammation 6/2014

01-12-2014

Orientin Inhibits High Glucose-Induced Vascular Inflammation In Vitro and In Vivo

Authors: Sae-Kwang Ku, Soyoung Kwak, Jong-Sup Bae

Published in: Inflammation | Issue 6/2014

Login to get access

Abstract

Vascular inflammation plays a key role in the initiation and progression of atherosclerosis, a major complication of diabetes mellitus. Orientin, a C-glycosyl flavonoid, is known to have anxiolytic and antioxidative activity. In this study, we assessed whether orientin can suppress vascular inflammation induced by high glucose (HG) in human umbilical vein endothelial cells (HUVECs) and mice. Our data indicate that HG markedly increased vascular permeability, monocyte adhesion, the expression of cell adhesion molecules (CAMs), the formation of reactive oxygen species (ROS), and the activation of nuclear factor kappa B (NF-κB). Remarkably, the vascular inflammatory effects of HG were attenuated by pretreatment with orientin. Since vascular inflammation induced by HG is critical in the development of diabetic complications, our results suggest that orientin may have significant benefits in the treatment of diabetic complications and atherosclerosis.
Literature
1.
go back to reference Whiting, D.R., L. Guariguata, C. Weil, and J. Shaw. 2011. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94: 311–321.PubMedCrossRef Whiting, D.R., L. Guariguata, C. Weil, and J. Shaw. 2011. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94: 311–321.PubMedCrossRef
2.
go back to reference Grundy, S.M., I.J. Benjamin, G.L. Burke, et al. 1999. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100: 1134–1146.PubMedCrossRef Grundy, S.M., I.J. Benjamin, G.L. Burke, et al. 1999. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100: 1134–1146.PubMedCrossRef
3.
go back to reference Thomas, J.E., and J.M. Foody. 2007. The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy. Journal of the Cardiometabolic Syndrome 2: 108–113.PubMedCrossRef Thomas, J.E., and J.M. Foody. 2007. The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy. Journal of the Cardiometabolic Syndrome 2: 108–113.PubMedCrossRef
4.
go back to reference Roglic, G., N. Unwin, P.H. Bennett, et al. 2005. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28: 2130–2135.PubMedCrossRef Roglic, G., N. Unwin, P.H. Bennett, et al. 2005. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28: 2130–2135.PubMedCrossRef
6.
go back to reference Day, C. 1998. Traditional plant treatments for diabetes mellitus: pharmaceutical foods. The British Journal of Nutrition 80: 5–6.PubMedCrossRef Day, C. 1998. Traditional plant treatments for diabetes mellitus: pharmaceutical foods. The British Journal of Nutrition 80: 5–6.PubMedCrossRef
7.
go back to reference Li, G.Q., A. Kam, K.H. Wong, et al. 2012. Herbal medicines for the management of diabetes. Advances in Experimental Medicine and Biology 771: 396–413.PubMed Li, G.Q., A. Kam, K.H. Wong, et al. 2012. Herbal medicines for the management of diabetes. Advances in Experimental Medicine and Biology 771: 396–413.PubMed
8.
go back to reference Kumar, S., and A.K. Pandey. 2013. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal 2013: 162750.PubMedCentralPubMed Kumar, S., and A.K. Pandey. 2013. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal 2013: 162750.PubMedCentralPubMed
9.
go back to reference Dietrych-Szostak, D., and W. Oleszek. 1999. Effect of processing on the flavonoid content in buckwheat (Fagopyrum esculentum Moench) grain. Journal of Agricultural and Food Chemistry 47: 4384–4387.PubMedCrossRef Dietrych-Szostak, D., and W. Oleszek. 1999. Effect of processing on the flavonoid content in buckwheat (Fagopyrum esculentum Moench) grain. Journal of Agricultural and Food Chemistry 47: 4384–4387.PubMedCrossRef
10.
go back to reference Soulimani, R., C. Younos, S. Jarmouni, D. Bousta, R. Misslin, and F. Mortier. 1997. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. Journal of Ethnopharmacology 57: 11–20.PubMedCrossRef Soulimani, R., C. Younos, S. Jarmouni, D. Bousta, R. Misslin, and F. Mortier. 1997. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. Journal of Ethnopharmacology 57: 11–20.PubMedCrossRef
11.
go back to reference Li, Y.L., S.C. Ma, Y.T. Yang, S.M. Ye, and P.P. But. 2002. Antiviral activities of flavonoids and organic acid from Trollius chinensis Bunge. Journal of Ethnopharmacology 79: 365–368.PubMedCrossRef Li, Y.L., S.C. Ma, Y.T. Yang, S.M. Ye, and P.P. But. 2002. Antiviral activities of flavonoids and organic acid from Trollius chinensis Bunge. Journal of Ethnopharmacology 79: 365–368.PubMedCrossRef
12.
go back to reference Budzianowski, J., G. Pakulski, and J. Robak. 1991. Studies on antioxidative activity of some C-glycosylflavones. Polish Journal of Pharmacology and Pharmacy 43: 395–401.PubMed Budzianowski, J., G. Pakulski, and J. Robak. 1991. Studies on antioxidative activity of some C-glycosylflavones. Polish Journal of Pharmacology and Pharmacy 43: 395–401.PubMed
13.
go back to reference Lee, W., S.K. Ku, and J.S. Bae. 2013. Emodin-6-O-beta-d-glucoside down-regulates endothelial protein C receptor shedding. Archives of Pharmacal Research 36: 1160–1165.PubMedCrossRef Lee, W., S.K. Ku, and J.S. Bae. 2013. Emodin-6-O-beta-d-glucoside down-regulates endothelial protein C receptor shedding. Archives of Pharmacal Research 36: 1160–1165.PubMedCrossRef
14.
go back to reference Bae, J.S., and A.R. Rezaie. 2013. Thrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand. BMB Reports 46: 544–549.PubMedCentralPubMedCrossRef Bae, J.S., and A.R. Rezaie. 2013. Thrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand. BMB Reports 46: 544–549.PubMedCentralPubMedCrossRef
15.
go back to reference Kim, T.H., S.K. Ku, I.C. Lee, and J.S. Bae. 2012. Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Reports 45: 200–205.PubMedCrossRef Kim, T.H., S.K. Ku, I.C. Lee, and J.S. Bae. 2012. Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Reports 45: 200–205.PubMedCrossRef
16.
go back to reference Bae, J.S., W. Lee, and A.R. Rezaie. 2012. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost 10: 1145–1151.PubMedCentralPubMedCrossRef Bae, J.S., W. Lee, and A.R. Rezaie. 2012. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost 10: 1145–1151.PubMedCentralPubMedCrossRef
17.
go back to reference Lee, J.D., J.E. Huh, G. Jeon, et al. 2009. Flavonol-rich RVHxR from Rhus verniciflua stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. International Immunopharmacology 9: 268–276.PubMedCrossRef Lee, J.D., J.E. Huh, G. Jeon, et al. 2009. Flavonol-rich RVHxR from Rhus verniciflua stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. International Immunopharmacology 9: 268–276.PubMedCrossRef
18.
go back to reference Bae, J.S., W. Lee, J.O. Nam, J.E. Kim, S.W. Kim, and I.S. Kim. 2014. Transforming growth factor beta-induced protein promotes severe vascular inflammatory responses. American Journal of Respiratory and Critical Care Medicine 189: 779–786.PubMedCrossRef Bae, J.S., W. Lee, J.O. Nam, J.E. Kim, S.W. Kim, and I.S. Kim. 2014. Transforming growth factor beta-induced protein promotes severe vascular inflammatory responses. American Journal of Respiratory and Critical Care Medicine 189: 779–786.PubMedCrossRef
19.
go back to reference Lee, W., S.K. Ku, D. Lee, T. Lee, and J.S. Bae. 2014. Emodin-6-O-beta-d-glucoside inhibits high-glucose-induced vascular inflammation. Inflammation 37: 306–313.PubMedCrossRef Lee, W., S.K. Ku, D. Lee, T. Lee, and J.S. Bae. 2014. Emodin-6-O-beta-d-glucoside inhibits high-glucose-induced vascular inflammation. Inflammation 37: 306–313.PubMedCrossRef
20.
go back to reference Mackman, N., K. Brand, and T.S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. The Journal of Experimental Medicine 174: 1517–1526.PubMedCrossRef Mackman, N., K. Brand, and T.S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. The Journal of Experimental Medicine 174: 1517–1526.PubMedCrossRef
21.
go back to reference Laakso, M. 1999. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48: 937–942.PubMedCrossRef Laakso, M. 1999. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48: 937–942.PubMedCrossRef
22.
go back to reference Wardle, E.N. 1994. Vascular permeability in diabetics and implications for therapy. Diabetes Research and Clinical Practice 23: 135–139.PubMedCrossRef Wardle, E.N. 1994. Vascular permeability in diabetics and implications for therapy. Diabetes Research and Clinical Practice 23: 135–139.PubMedCrossRef
23.
go back to reference Hamuro, M., J. Polan, M. Natarajan, and S. Mohan. 2002. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 162: 277–287.PubMedCrossRef Hamuro, M., J. Polan, M. Natarajan, and S. Mohan. 2002. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 162: 277–287.PubMedCrossRef
24.
go back to reference Morigi, M., S. Angioletti, B. Imberti, et al. 1998. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. The Journal of Clinical Investigation 101: 1905–1915.PubMedCentralPubMedCrossRef Morigi, M., S. Angioletti, B. Imberti, et al. 1998. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. The Journal of Clinical Investigation 101: 1905–1915.PubMedCentralPubMedCrossRef
25.
go back to reference Boisvert, W.A. 2004. Modulation of atherogenesis by chemokines. Trends in Cardiovascular Medicine 14: 161–165.PubMedCrossRef Boisvert, W.A. 2004. Modulation of atherogenesis by chemokines. Trends in Cardiovascular Medicine 14: 161–165.PubMedCrossRef
26.
go back to reference Dunlop, M. 2000. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney International. Supplement 77: S3–S12.PubMedCrossRef Dunlop, M. 2000. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney International. Supplement 77: S3–S12.PubMedCrossRef
27.
go back to reference Han, H.J., Y.J. Lee, S.H. Park, J.H. Lee, and M. Taub. 2005. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. American Journal of Physiology. Renal Physiology 288: F988–F996.PubMedCrossRef Han, H.J., Y.J. Lee, S.H. Park, J.H. Lee, and M. Taub. 2005. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. American Journal of Physiology. Renal Physiology 288: F988–F996.PubMedCrossRef
28.
go back to reference Rimbach, G., G. Valacchi, R. Canali, and F. Virgili. 2000. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Molecular Cell Biology Research Communications 3: 238–242.PubMedCrossRef Rimbach, G., G. Valacchi, R. Canali, and F. Virgili. 2000. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Molecular Cell Biology Research Communications 3: 238–242.PubMedCrossRef
29.
go back to reference Uemura, S., H. Matsushita, W. Li, et al. 2001. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circulation Research 88: 1291–1298.PubMedCrossRef Uemura, S., H. Matsushita, W. Li, et al. 2001. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circulation Research 88: 1291–1298.PubMedCrossRef
30.
go back to reference Kannel, W.B., and D.L. McGee. 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035–2038.PubMedCrossRef Kannel, W.B., and D.L. McGee. 1979. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035–2038.PubMedCrossRef
31.
go back to reference Nannipieri, M., L. Rizzo, A. Rapuano, A. Pilo, G. Penno, and R. Navalesi. 1995. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 18: 1–9.PubMedCrossRef Nannipieri, M., L. Rizzo, A. Rapuano, A. Pilo, G. Penno, and R. Navalesi. 1995. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 18: 1–9.PubMedCrossRef
32.
go back to reference Tooke, J.E. 1995. Microvascular function in human diabetes. A physiological perspective. Diabetes 44: 721–726.PubMedCrossRef Tooke, J.E. 1995. Microvascular function in human diabetes. A physiological perspective. Diabetes 44: 721–726.PubMedCrossRef
33.
go back to reference Gerrity, R.G. 1981. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. The American Journal of Pathology 103: 181–190.PubMedCentralPubMed Gerrity, R.G. 1981. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. The American Journal of Pathology 103: 181–190.PubMedCentralPubMed
34.
go back to reference Esposito, C., G. Fasoli, A.R. Plati, et al. 2001. Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney International 59: 1842–1849.PubMedCrossRef Esposito, C., G. Fasoli, A.R. Plati, et al. 2001. Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney International 59: 1842–1849.PubMedCrossRef
35.
go back to reference Lopes-Virella, M.F., and G. Virella. 1992. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41(Suppl 2): 86–91.PubMedCrossRef Lopes-Virella, M.F., and G. Virella. 1992. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes 41(Suppl 2): 86–91.PubMedCrossRef
36.
go back to reference Bae, J.S. 2012. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 35: 1511–1523.PubMedCrossRef Bae, J.S. 2012. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 35: 1511–1523.PubMedCrossRef
37.
go back to reference Kado, S., T. Wakatsuki, M. Yamamoto, and N. Nagata. 2001. Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sciences 68: 727–737.PubMedCrossRef Kado, S., T. Wakatsuki, M. Yamamoto, and N. Nagata. 2001. Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sciences 68: 727–737.PubMedCrossRef
38.
go back to reference Hansson, G.K., and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nature Reviews. Immunology 6: 508–519.PubMedCrossRef Hansson, G.K., and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nature Reviews. Immunology 6: 508–519.PubMedCrossRef
39.
go back to reference Inoguchi, T., P. Li, F. Umeda, et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939–1945.PubMedCrossRef Inoguchi, T., P. Li, F. Umeda, et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939–1945.PubMedCrossRef
Metadata
Title
Orientin Inhibits High Glucose-Induced Vascular Inflammation In Vitro and In Vivo
Authors
Sae-Kwang Ku
Soyoung Kwak
Jong-Sup Bae
Publication date
01-12-2014
Publisher
Springer US
Published in
Inflammation / Issue 6/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9950-x

Other articles of this Issue 6/2014

Inflammation 6/2014 Go to the issue